Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ARO-DM1 FOR injection----1件: 113 💬
2Biologic dmards----1件: 107 💬
3Biologic or targeted synthetic dmard----2件: 46, 271 💬
4Biological dmards----2件: 86, 107 💬
5Classic dmards treatment group----1件: 46 💬
6CO-medication: synthetic dmards----1件: 46 💬
7Combination OF dmards----1件: 107 💬
8Conventional dmard combination----1件: 46 💬
9Conventional dmards----1件: 46 💬
10Conventional synthetic dmard----1件: 46 💬
11Dextromethorphan
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 6, 8, 13, 21, 85, 96, 97, 156 💬
12Dextromethorphan 30 MG
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 96, 97 💬
13Dextromethorphan HBR and quinidine sulfate
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 2 💬
14Dextromethorphan hydrobromide
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 13, 46 💬
15Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 2, 13 💬
16Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG
(Benylin DM)		1件: Dextromethorphan3件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM) 💬 		6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 2, 13 💬
17Dextromethorphan/quinidine
(Benylin DM)		2件: Dextromethorphan,
Quinidine		7件: Quinidine gluconate ,
Quinidine polygalacturonate ,
Dextromethorphan hydrobromide (Benylin DM),
Quinidine sulfate ,
Dextromethorphan ,
Daunorubicin (DM),
Quinidine 💬 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬 		23件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
18Dimebon + dextromethorphan
(Benylin DM)		2件: Dextromethorphan,
Latrepirdine		5件: Dextromethorphan hydrobromide (Benylin DM),
Dextromethorphan ,
Daunorubicin (DM),
Latrepirdine ,
Latrepirdine dihydrochloride 💬 		7件: ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬 		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 8 💬
19DM-1992----1件: 6 💬
20DM1-activc----1件: 113 💬
21Dmard----1件: 46 💬
22Dmard cessation----1件: 46 💬
23Dmard maintenance----1件: 46 💬
24Dmard therapy----1件: 46 💬
25Dmards----2件: 46, 271 💬
26Dmards (methotrexate----1件: 46 💬
27Dmards or biologics----1件: 46 💬
28Dmps1件: 2,3-Dimercapto-1-propanesulfonic acid (DMPS)---1件: 171 💬
29Dmsa1件: Succimer (DMS-A)1件: Succimer 💬 --1件: 171 💬
30Dmso1件: Dimethyl sulfoxide (DMSO)1件: Dimethyl sulfoxide 💬 --1件: 226 💬
31Dmso cocktail1件: Dimethyl sulfoxide (DMSO)1件: Dimethyl sulfoxide 💬 --1件: 226 💬
32DMT----1件: 13 💬
33DMT category 1----1件: 13 💬
34DMT continuation----1件: 13 💬
35DMT withdrawal----1件: 13 💬
36DMX-200----1件: 222 💬
37Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), ETC1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
38Exposure TO ONE or more disease-modifying drug(S)(dmds) used TO treat MS----1件: 13 💬
39First line DMT----1件: 13 💬
40HUC-MSC + dmards----1件: 46 💬
41Injectable MS DMT----1件: 13 💬
42Ionis-dmpkrx----1件: 113 💬
43NON-biologic dmards----3件: 46, 86, 107 💬
44NON-biological dmards----1件: 46 💬
45Nonbiologic dmards OF investigator'S choice----1件: 46 💬
46Other dmards----1件: 46 💬
47Patient treated with dmard----1件: 46 💬
48Permitted dmards----1件: 46 💬
49Phase 1: conventiaonal dmard----1件: 46 💬
50Select dmts other than ozanimod1件: Ozanimod2件: Ozanimod hydrochloride ,
Ozanimod 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
51Standard MS DMT----1件: 13 💬
52Standard MS dmts----1件: 13 💬
53Targeted synthetic dmard class----1件: 46 💬
54TNF-A antagonists, NON-tnfs, dmard NON-biologics----3件: 46, 97, 271 💬
55Trivalent chromium versus synthetic and/ or biological dmards----1件: 46 💬
56UC-MSC+dmards----1件: 46 💬
57Usual DMT continuation----1件: 13 💬